You are here

News

subscribe

The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.

31 July 2020

‘Significant step’ as HIV prevention vaginal ring meets with positive reception from the European Medicines Agency

Ring containing the antiretroviral drug dapivirine could be available in Africa as early as 2021 after it was found to reduce women’s HIV risk by 30 to 50%.

23 July 2020

Injectable PrEP – an exciting tool, but no silver bullet for adherence

We talk to Giffin Daughtridge, CEO of medical diagnostics company, UrSure, about treatment adherence and the impact of long-acting cabotegravir as injectable PrEP.

23 June 2020

Hundreds of young Nigerians crowdsource ideas to improve HIV self-testing

Peer distribution, youth branding and social media campaigns emerge as top ideas in crowdsourcing contest to improve HIV self-testing among young people.

11 June 2020

Non-medical fabric face masks can limit the spread of COVID-19

World Health Organization changes its position on the wearing of non-medical fabric face masks.

21 May 2020

Global trial of long-acting injectable PrEP for gay men and trans women stopped early following success

Long-acting, injectable cabotegravir is as effective as daily PrEP pills at preventing HIV among cisgender men and transgender women who have sex with men.

03 April 2020

HIV and COVID-19: six ways you can look after your health

If you’re living with HIV and wondering how the new coronavirus may affect you, here are some tips to help you look after yourself.

06 March 2020

PrEP could avert up to 8% of new infections by 2030

Modelling finds PrEP has the potential to avert between 3 and 8% of HIV infections in 13 African and Caribbean countries by 2030 if three key populations can access it

11 February 2020

Only half of those on HIV treatment are virally suppressed in Ghana

Viral load testing trial finds 49% are virally unsuppressed while one in five are failing their treatment with suspected drug resistance.

07 February 2020

PrEP during pregnancy: safety evidence ‘reassuring’ but gaps remain

Research on PrEP safety for pregnant women and their babies finds no adverse effects – but knowledge gaps remain.  

28 January 2020

Taking PrEP alongside oestrogen ‘may limit’ its effectiveness, study warns

Study with transgender women suggests taking on-demand PrEP with hormone therapy may result in drug levels too low for HIV prevention.